Eva Kalias

Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Ducera Partners LLC is an independent investment banking advisory firm that specializes in strategic advisory, mergers & acquisitions, restructuring, liability management, capital markets, and wealth management. The private company is based in New York, NY. The firm also provides growth capital to early-stage companies through its Ducera Investments platform. Since its founding in 2015, Ducera Partners has advised on over $750 billion in transactions across various industries. The company was founded in 2015 by Michael A. Kramer. Michael A. Kramer has been the CEO since 2015.

Part of Johnson & Johnson, Actelion Pharmaceuticals Korea Ltd. is a South Korean pharmaceutical company that manufactures pharmaceutical products. The company is based in Seoul, South Korea. The company was founded in 1983. The CEO is Jenny Jeong.

Actelion Pharmaceuticals Sverige AB conducts research, development, manufacture, and trade and marketing of pharmaceutical and medical products. The firm wholesales medical equipment and pharmaceutical medicine. It also develops and markets new drugs in the therapeutic areas of pulmonary arterial hypertension. The company founded in 2002 and is headquartered in Danderyd, Sweden.

Actelion Pharmaceuticals Italia Srl wholesales and distributes prescription drugs, proprietary and toiletries. The company is headquartered in Imola, Italy.

Takeda Pharma AG engages in the distribution of pharmaceutical products. It offers vaccines and medicines for the treatment of diseases focused on oncology, gastroenterology, and central nervous system therapy. The company was founded on November 19, 1986 and is headquartered in Pfaeffikon, Switzerland.

Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland.

Part of Guggenheim Partners LLC, Millstein & Co. LP is an alternative investment manager. The company is based in New York, NY. The CEOs are Elizabeth Abrams, James E. Millstein. The company was founded by James E. Millstein, Jim Millstein. Millstein & Co. was acquired by Guggenheim Securities LLC on September 17, 2018.

Adello Biologics LLC develops and supplies biosimilar recombinant therapeutic proteins. It also offers antibody products for major regulated markets and strategic markets globally. The company was founded by Sarfaraz K. Niazi and is headquartered in Piscataway, NJ.

Arxada AG is a Swiss specialty chemicals company that offers consumer microbial control, industrial microbial control, and specialty product solutions. The company is based in Basel, CH, and has subsidiaries in the Netherlands, United States, and Thailand. The company provides a wide range of differentiated products for various end markets, including hygiene, home and personal care, wood protection, crop protection, and food, beverage, and water. Arxada has leading regulatory capabilities, IP expertise, and an established track record in the industry. C. Marc Doyle has been the CEO of the company since 2021.

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Part of Ipsen SA, Ipsen Pharmaceuticals Ltd. is a company headquartered in Ireland that operates as a biopharmaceutical company that develops medicines.

Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig.

Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006.

Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany.

1-800 Contacts, Inc. retails and sells contact lenses. Its products include disposable contact lenses, toric, color, bifocal lenses and accessories. The firm offers all brands of contact lenses and also offers eyeglasses and sunglasses. The company was founded by Jonathan C. Coon and John F. Nichols in 1995 and is headquartered in Orem, UT.

Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford.

Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million.